Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and Hub Group, Inc. (NASDAQ: HUBG); Grabar Law Office is Investigating Claims on Your Behalf

$AARDPress releaseAug 27, 2026, 8:50 AM ETRead the release

Grabar Law Office is soliciting long-term shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD) for a shareholder governance action concerning alleged fiduciary duty breaches tied to the safety of its lead drug candidate, ARD-101. The investigation follows a securities class action alleging misleading statements regarding ARD-101’s safety profile and the subsequent FDA clinical hold.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.